SCHEMBL27716615

SCHEMBL27716615

Cc1ccc(N=S(=O)=O)cc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 5/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ CASP1 P29466 1/20 0.45
▸ MAPT P10636 5/20 0.42
▸ CYP3A4 P08684 7/20 0.42
▸ TSHR P16473 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ MAPK1 P28482 3/20 0.34
▸ PHLPP2 Q6ZVD8 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TRPA1 O75762 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27576407 0.81 PMM2 (0.41) TDP1ALDH1A1MAPTCYP3A4TSHR
SCHEMBL10068111 0.77 TDP1 (0.50) TDP1ALDH1A1CASP1MAPTCYP3A4
SCHEMBL28233514 0.76 MAPT (0.60) TDP1ALDH1A1CASP1MAPTCYP3A4
SCHEMBL28233516 0.76 MAPT (0.60) TDP1ALDH1A1CASP1MAPTCYP3A4
SCHEMBL27716593 0.76 LMNA (0.32) TDP1ALDH1A1MAPTLMNA
SCHEMBL27716582 0.76 TSHR (0.45) TDP1ALDH1A1MAPTCYP3A4TSHR
SCHEMBL28294225 0.74 KIF11 (0.32) CYP3A4TRPA1
SCHEMBL27737509 0.73 CD44 (0.33) ALDH1A1MAPTCYP3A4GAA
SCHEMBL28672997 0.72 ALDH1A1 (0.44) TDP1ALDH1A1CYP3A4TSHRKDM4E
SCHEMBL13479105 0.72 CYP3A4 (0.63) TDP1ALDH1A1CASP1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348203-B Inhibit the composition and method of JAK approach 里格尔药品股份有限公司 2018-09-18 — — CN disclosed
CN-106420756-A Compositions and methods for inhibition of the JAK pathway 里格尔药品股份有限公司 2017-02-22 — — CN disclosed
CN-105348203-A Compositions and methods for inhibition of the JAK pathway RIGEL PHARMACEUTICALS INC 2016-02-24 — — CN disclosed
CN-103533938-A 2,4 substituted pyrimidinediamines for use in discoid lupus RIGEL PHARMACEUTICALS INC 2014-01-22 — — CN disclosed
CN-102470135-A Compositions and methods for inhibiting the JAK pathway RIGEL PHARMACEUTICALS INC 2012-05-23 — — CN disclosed
CN-101282945-A Compositions and methods for inhibiting the JAK pathway RIGEL PHARMACEUTICALS INC (US) 2008-10-08 — — CN disclosed
Send feedback